Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452642 · ClinicalTrials.gov registry record · NA
The Supporting Understanding of PCOS Education and Research (SUPER) Study
A NA study of Polycystic Ovary, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 223
- Enrollment target
- 1
- Study location
NCT05452642: Active NA study of Polycystic Ovary, sponsored by University of Michigan.
NCT05452642 is a NA study of Polycystic Ovary that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 223 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05452642, a NA study of Polycystic Ovary, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor and a body composition scan (called a dual-energy x-ray absorptiometry or DEXA). Once these enrollment steps are completed and the participants will be randomized to one of two 12-month programs.
Primary Outcome
percentage of glycosylated hemoglobin
Conditions Studied
Interventions
- BEHAVIORAL DASH diet
- BEHAVIORAL Very low-carbohydrate diet
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2026-07-15 |
| Phase | NA |
What the registry record for NCT05452642 still lists
NCT05452642 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Polycystic Ovary appearing as the primary indexed condition, and to 2 interventions - of which DASH diet is the first listed.
NCT05452642 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05452642 about?
NCT05452642 is a clinical study titled "The Supporting Understanding of PCOS Education and Research (SUPER) Study". This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing...
What is the current status of trial NCT05452642?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2022-08-15. Estimated completion is 2026-07-15.
What conditions does trial NCT05452642 study?
This clinical trial studies the following conditions: Polycystic Ovary.
What interventions are being tested in trial NCT05452642?
The interventions under investigation include: DASH diet (BEHAVIORAL), Very low-carbohydrate diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05452642?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05452642 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05452642's enrollment target sits among peer trials
223 481st of 2000 higher than 1,520 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI